Good evening :)
Place Order
Add to Watchlist

Medinova Diagnostic Services Ltd

MEDINOV

Medinova Diagnostic Services Ltd

MEDINOV
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹40 cr, stock is ranked 3,653
High RiskStock is 3.69x as volatile as Nifty
41.002.76% (+1.10)
41.002.76% (+1.10)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹40 cr, stock is ranked 3,653
High RiskStock is 3.69x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹40 cr, stock is ranked 3,653
High RiskStock is 3.69x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
21.03-12.94
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.096.400.53%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Medinova Diagnostic Services is engaged in the business of providing medical diagnostic services and related busines

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -0.59%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.03% to 0.02%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 19.81%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue8.259.5610.3010.687.5212.8813.3510.2210.3710.14
Raw Materialssubtract0.991.130.000.000.000.000.000.000.007.10
Power & Fuel Costsubtract0.500.440.380.350.350.340.350.340.37
Employee Costsubtract2.322.152.192.201.921.731.981.981.90
Selling & Administrative Expensessubtract3.343.183.092.692.302.082.112.332.40
Operating & Other expensessubtract0.950.792.432.411.685.595.002.702.67
Depreciation/Amortizationsubtract1.922.661.881.290.950.720.550.330.130.13
Interest & Other Itemssubtract0.521.060.840.660.590.460.560.650.620.53
Taxes & Other Itemssubtract-0.39-0.10-0.060.27-0.02-0.060.530.230.280.46
EPS-2.01-1.80-0.450.81-0.252.022.271.662.001.92
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Medinova Diagnostic Services Ltd20.19-12.94
Apollo Hospitals Enterprise Ltd110.9713.620.23%
Max Healthcare Institute Ltd91.9111.560.15%
Fortis Healthcare Ltd86.466.050.15%

Price Comparison

Compare MEDINOV with any stock or ETF
Compare MEDINOV with any stock or ETF
MEDINOV
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding62.14%0.00%0.00%0.00%37.86%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

MEDINOV has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Medinova Diagnostic Services consolidated net profit declines 24.24% in the September 2024 quarter

Net profit of Medinova Diagnostic Services declined 24.24% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.66 crore during the previous quarter ended September 2023. Sales declined 10.80% to Rs 2.56 crore in the quarter ended September 2024 as against Rs 2.87 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2.562.87 -11 OPM %31.2531.71 - PBDT0.700.78 -10 PBT0.660.75 -12 NP0.500.66 -24 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Medinova Diagnostic Services announces board meeting date

Medinova Diagnostic Services will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Medinova Diagnostic Services to conduct AGM

Medinova Diagnostic Services announced that the Annual General Meeting (AGM) of the company will be held on 3 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Medinova Diagnostic Services consolidated net profit rises 27.27% in the June 2024 quarter

3 months agoBusiness Standard
Earnings
Medinova Diagnostic Services consolidated net profit rises 27.27% in the June 2024 quarter

Net profit of Medinova Diagnostic Services rose 27.27% to Rs 0.42 crore in the quarter ended June 2024 as against Rs 0.33 crore during the previous quarter ended June 2023. Sales rose 2.89% to Rs 2.49 crore in the quarter ended June 2024 as against Rs 2.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2.492.42 3 OPM %27.7121.90 - PBDT0.590.41 44 PBT0.550.38 45 NP0.420.33 27 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Medinova Diagnostic Services to declare Quarterly Result

Medinova Diagnostic Services will hold a meeting of the Board of Directors of the Company on 30 July 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Board of Vijaya Diagnostic Centre approves merger with Medinova Diagnostic Services

4 months agoBusiness Standard

Medinova Diag Standalone June 2023 Net Sales at Rs 1.82 crore, down 5.7% Y-o-Y

1 year agoMoneycontrol

Medinova Diagnostic Services consolidated net profit declines 33.33% in the September 2022 quarter

2 years agoBusiness Standard

Medinova Diag Consolidated March 2022 Net Sales at Rs 2.70 crore, down 2.52% Y-o-Y

2 years agoMoneycontrol